TotalMarketCap

Aktis Oncology

AKTSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$820.944 M

$14.76 -2.90%

Close of 6 Nov 2026

As of 6 Nov 2026, Aktis Oncology (AKTS) has a market capitalization of $820.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

53,446,222

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #156Syndax PharmaceuticalsSNDX$842.8M
  2. #157Corvus PharmaceuticalsCRVS$821.0M
  3. #158Aktis OncologyAKTS$820.9M
  4. #159Collegium PharmaceuticalCOLL$816.5M
  5. #160CryoportCYRX$813.4M

What if Aktis Oncology were worth as much as…

Open the what-if tool →

Gold $28.2T

$507,679.40

Per share 34,396× higher

Bitcoin $1.53T

$27,469.65

Per share 1,861× higher

Apple $5.02T

$90,180.29

Per share 6,110× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Aktis Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.